In the previous study of McNeill et al., APEX1-deficient cells were shown to exhibit the greatest sensitivity to antimetabolites among various anticancer drugs, and consequently apoptotic cell death was profoundly increased, supporting a role for mutant APEX1 in thiopurine-induced neutropenia [23]. The gene discussed is APEX1; the disease is neutropenia.